In a previous study, fatty acids accumulation in the liver was found to induce mitochondrial β-oxidation [36], and an increase in CPT1 expression through PPARα activation was observed in the livers of rodents and patients with NAFLD [37]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.